You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -105,205.3% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -3.3 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 4,917.4 | 0.0 |
| Price / Book value | 253.2 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 0.91 | -1.36 | €-0.09 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2015-12-31 | 0.52 | -6.15 | €-0.30 | -11.1 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 0.95 | -10.06 | €-0.42 | -7.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -21.06 | €-0.76 | -11.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 0.02 | -20.08 | €-0.65 | -0.9 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 0.00 | 0.00 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee Sharecast News | 09 Oct |
|---|---|
| Faron Pharmaceuticals hits bump in road for Traumakine manufacturing Sharecast News | 02 Oct |
| Faron Pharma raises £2.3m to keep it going through the start of 2020 Sharecast News | 27 Aug |
| Holdings in Company | 21-Nov-19 14:00 |
|---|---|
| Price Monitoring Extension | 21-Nov-19 09:01 |
| Application to Nasdaq First North Growth Market | 21-Nov-19 07:27 |
| Second Price Monitoring Extn | 19-Nov-19 11:06 |
| Price Monitoring Extension | 19-Nov-19 11:01 |